The Unted States Patent and Trademark Office (USPTO) recently published new guidance on subject-matter eligibility as related to Artificial Intelligence
Continue Reading This Summer in Artificial Intelligence: Newly Released USPTO Guidance and Exemplary Worldwide Inventorship Updates
Heading into 2025, patent applicants should prepare for significant fee increases at the United States Patent and Trademark Office (USPTO).
Continue Reading USPTO Fees Are Rising Drastically in 2025: What to Do Now to Save Thousands of Dollars
BASE Air is a company at the leading edge of safety in the heavy vehicle industry. Founded in 2005 by
Continue Reading Client Spotlight: BASE Air Management
In a long-awaited milestone in the gene therapy space, the Food and Drug Administration (FDA) approved two gene therapies to
Continue Reading Gene Therapy Approvals Gain Steam in 2023: FDA Approves First Gene Therapies for Sickle Cell Disease
Gene therapy is part of a new wave of medicine that approaches disease treatment by addressing the root causes rather
Continue Reading Gene Therapy Approvals Gain Steam in 2023: Milestones in Second Half Pave Way for Transformative 2024
After decades of intense scientific research into developing gene editing technologies, and more than a few setbacks, the field has
Continue Reading Gene Therapy Approvals Gain Steam in 2023: Treatments Offer New Hopes for Rare Diseases
Guest Post By Leena Chitnis, Founder & CEO, Timberdog®
In today’s fast-paced business environment, intellectual property (IP) has become
Continue Reading How I Protected My Intellectual Property on a Lean Budget
The alternative (“alt-“) animal products industry is growing increasingly more popular each year, causing an increased demand in foods made
Continue Reading Foodtech Patents: Who’s on the Board and What Moves are they Making?
Federal funding is a huge boon for companies, universities, and research institutions conducting innovative research. However, it comes attached with
Continue Reading Keeping Your Federally-Funded Inventions: Requirements to Comply with the Bayh-Dole Act
Gene therapies have been the subject of tremendous scientific research and investment. With hundreds of clinical trials in progress and
Continue Reading The Evolving Gene Editing Landscape: From Research Tool to Market